Pantoprazole 40mg + Domperidone 30mg SR Capsules

Experience powerful and long-lasting relief from gastrointestinal discomfort with Pantoprazole 40mg and Domperidone 30mg Sustained Release Capsules. Formulated to control excess stomach acid and improve gastric motility, this combination effectively alleviates symptoms of GERD, heartburn, indigestion, bloating, and nausea. Packaged in premium Alu-Alu blister packaging containing 10 strips of 10 capsules each (100 capsules total) for maximum stability and freshness.

Pantoprazole 40 mg + Domperidone 30 mg SR Capsules is a combination pharmaceutical formulation containing Pantoprazole, a proton pump inhibitor (PPI), and Domperidone, a prokinetic and antiemetic agent in a sustained-release (SR) formulation. This combination is intended for selected patients experiencing acid-related gastrointestinal symptoms accompanied by nausea or delayed stomach emptying, when both ingredients are considered appropriate by a healthcare professional. Pantoprazole works by inhibiting the proton pumps in the stomach lining responsible for acid secretion, thereby reducing gastric acid production and helping manage conditions such as gastroesophageal reflux disease (GERD), acid reflux, heartburn, and certain acid-related disorders. Domperidone acts primarily on dopamine receptors involved in gastrointestinal function and may help improve stomach emptying and relieve nausea and vomiting. The 40 mg + 30 mg SR capsule formulation combines acid suppression with sustained-release delivery of Domperidone, which is designed to release the active ingredient over an extended period according to the product's formulation. Potential side effects include headache, abdominal discomfort, diarrhoea, dry mouth, and dizziness. Domperidone can cause serious heart rhythm disturbances in some patients, particularly those with cardiac disease, electrolyte imbalances, liver problems, or those taking medicines that interact with it. Its use is restricted in many settings to specific indications, the lowest effective dose, and the shortest appropriate duration. Patients should inform their healthcare professional about existing medical conditions and all medicines they take before starting treatment. The SR capsule should be used according to the product-specific instructions and should not be crushed or altered unless the product information explicitly permits it. Pantoprazole 40 mg + Domperidone 30 mg SR Capsules should be used only under medical supervision, with the appropriateness of the Domperidone sustained-release strength verified against the approved product label and local prescribing guidance.